#Melanoma Research Alliance

Research is conﬁrming that artiﬁcial intelligence and machine learning algorithms may revolutionize the speed of melanoma diagnosis.

Watch MRA CEO Dr. Marc Hurlbert and Army Veteran Andrew Smith discuss the risk of this skin cancer among the military and veterans.

Roughly nine out of ten skin cancers— including melanoma—are caused by unprotected exposure to UV rays.

Adjuvant immunotherapy can help reduce the likelihood of the skin cancer returning, but is more better or is less more?

Reducing the risk of this deadly skin cancer recurring after surgery is an important goal, notes the Melanoma Research Alliance.

Melanoma Research Alliance interviews Dr. Hussein Tawbi, who led a clinical trial on the immunotherapy drug Opdualag.

Melanoma skin cancer cells may spread, or metastasize, in the brain and cerebrospinal ﬂuid. Here’s a roundtable discussion on the topic.

Surgery for this rare cancer required the removal of Walther’s left eye. “This is my journey,” she said, “and I have to travel it.”

The Melanoma Research Alliance’s Patient Advocate Scientific Retreat and Patient Forum take place in DC during February 2024.

When cancer treatment made her feel uncomfortable in everyday clothing, Paloma Soledad founded Krysalis Kouture.

These individuals work to ensure fair opportunities to prevent, treat and survive cancer.

Jamie Goldfarb and Ken Billett, both melanoma survivors, share how their lives have been shaped by recent advances in melanoma research.

The field is light years from where it started.

Learn more about melanoma risk factors, hereditary melanoma, and genetic testing.

He experienced his worst sunburn during a deployment to Iraq. Now free of skin cancer, Andrew Smith practices sun safety with his family.

15 new treatments for advanced melanoma have earned FDA approval since 2011, including targeted therapies and immunotherapy.